top of page
The [Daily] Leaflets


AI Ready
You are AI-Ready. The only thing left is a mind-shift, and it can happen quick. How quick? Here is a text I wrote three days ago: AI-Readiness doesn’t start with a decision which model to use or to learn how to vibe code. It starts with an ontology - a shared meaning and structure of our Knowledge. A common source of Truth. Just between us, the Humans - a minute before we let the Robot into the party. Once we feed our knowledge into the machine, this Ontology will provide i
Jan 102 min read


Digital by Design
FAIR is a control strategy, not just a data format. Quality by Design defines how we build quality into products. Digital by Design defines how we build quality into knowledge. Design your process such that data capture is commensurate to the value/risk associated with it. Minimizing Data loss minimizes opportunity loss, and ensures Knowledge of Quality is consistently obtained. In the world of Big Data and AI, Knowledge Quality is all there is. ================== Bypass the
Jan 71 min read


The 5 percent
What will you do in the world of the 5%?
Jan 51 min read


Potency Assurance Strategy
In this revised draft, FDA gives a substantial facelift to its original 2011 guideline on Potency assays for Cell and Gene Therapies. It introduces a holistic "Potency assurance strategy" that encompasses a thorough understanding of the product MOA, QTPP and "Potency-related" CQAs (because in these therapies- potency is achieved by a combination of factors usually). It emphasizes the big picture of process understanding and a risk-based control strategy and makes several refe
Dec 30, 20231 min read


Critical Thinking
“When everything is critical, nothing is critical” So goes the saying… And indeed, it’s a tough conundrum- because in Pharma, we have to...
Dec 25, 20231 min read


Big Data vs. Big Pharma
AI is big but Pharma is bigger. Let me rephrase: AI applications for Pharma and Drug Development are being developed for very specific...
Dec 21, 20231 min read


Hidden Opportunities
Regulatory submissions are an inherent part of drug development. They are often considered as an “event” that a project goes through when...
Dec 19, 20232 min read


Take it personally
You are a unique snowflake. You like your coffee with Soy milk, in a thick glass, with no sugar, and extra foam. And it must be boiling...
Dec 15, 20232 min read


Careful Innovation
Yesterday’s "Early Adopters" has made some waves in our little pond, and brought up two fundamental questions. So let’s roll our sleeves...
Dec 14, 20232 min read


Early Adopters
When I just joined in the Pharma industry, they told me we are very conservative with new technologies because we are a highly regulated...
Dec 13, 20232 min read


The Rare Disease CMC Crunch
Drug development is slow. Tell this to a mother or a father of a suffering child, or the terminally-ill on their deathbed. Still…There is...
Dec 12, 20232 min read


The Documentation Paradox
I have a million photos of my daughters. Per week. You can literally run them sequentially and get a stop motion video of every single...
Dec 11, 20232 min read


The 7 Stages of Compliance
The seven stages of regulatory compliance, in a Biotech Startup: Denial- “we only need to think about it when we’ve secured funding for...
Dec 10, 20232 min read


Regulatory "Events"
Most startups consider their regulatory submissions as a singular “Event”. One that takes place when approaching the regulatory authority...
Nov 25, 20232 min read


Knowledge Culture
Everyone talks about Quality Culture, but what about Knowledge Culture? What is there to “culture” about knowledge, anyway? ICH Q10...
Nov 24, 20232 min read


Don’t call me name(s)
How do you call an impurity never seen before? Impurity X is already taken, as it was the first one observed, and X is the most popular...
Nov 23, 20232 min read


Stop Wasting your Knowledge!
Knowledge in Pharma is expensive. Hundreds of millions of dollars expensive. No surprise new drugs cost so much, and many don’t make it...
Nov 20, 20231 min read


Somewhere over the rainbow...
Somewhere over the rainbow, there’s: The funding round The clinical trial interim results The next stability time point THE manufacturing...
Oct 4, 20232 min read


Knowledge, Risk and Benefit
Drug Development is a knowledge-intensive, Risk-intensive endeavor, and we target to establish a very high-quality manufacturing...
Oct 3, 20231 min read


Tech-Knowledgy Transfer
They say that the things you like most about your partner at the beginning become the things that annoy you most later on in life.... In...
Oct 2, 20232 min read


QTPP of a Boiled Egg...
If you ever peeled a hard-boiled egg, you know it doesn’t always come out right. Sometimes it sticks, leaving behind a patchy egg white...
Oct 1, 20231 min read


Digital Swimming lessons
Tossing your child into the deep end of the pool is a sure way to teach them fast. But what does it teach them? They surely learn how not...
Sep 5, 20232 min read


ICH guidelines and the tower of Babel
Pride and arrogance are not something new. We all saw what happened in the Tower of Babel, but we don’t have to look hard and find more...
Jul 24, 20232 min read


Don't grow up, it's a trap!
Don’t grow up, it’s a trap! Seriously. Don't. If you are young, and reading this- you probably know this joke already, but I urge you to...
Jul 9, 20232 min read
bottom of page